Comparison of spinal magnetic resonance imaging and classical clinical factors in predicting motor capacity in amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis Biomarkers Disease progression rate Motor neuron disorder Spinal cord MRI

Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 19 03 2023
accepted: 12 04 2023
revised: 10 04 2023
medline: 17 7 2023
pubmed: 27 4 2023
entrez: 27 4 2023
Statut: ppublish

Résumé

Motor capacity is crucial in amyotrophic lateral sclerosis (ALS) clinical trial design and patient care. However, few studies have explored the potential of multimodal MRI to predict motor capacity in ALS. This study aims to evaluate the predictive value of cervical spinal cord MRI parameters for motor capacity in ALS compared to clinical prognostic factors. Spinal multimodal MRI was performed shortly after diagnosis in 41 ALS patients and 12 healthy participants as part of a prospective multicenter cohort study, the PULSE study (NCT00002013-A00969-36). Motor capacity was assessed using ALSFRS-R scores. Multiple stepwise linear regression models were constructed to predict motor capacity at 3 and 6 months from diagnosis, based on clinical variables, structural MRI measurements, including spinal cord cross-sectional area (CSA), anterior-posterior, and left-to-right cross-section diameters at vertebral levels from C1 to T4, and diffusion parameters in the lateral corticospinal tracts (LCSTs) and dorsal columns. Structural MRI measurements were significantly correlated with the ALSFRS-R score and its sub-scores. And as early as 3 months from diagnosis, structural MRI measurements fit the best multiple linear regression model to predict the total ALSFRS-R (R Spinal multimodal MRI could be promising as a tool to enhance prognostic accuracy and serve as a motor function proxy in ALS.

Sections du résumé

BACKGROUND BACKGROUND
Motor capacity is crucial in amyotrophic lateral sclerosis (ALS) clinical trial design and patient care. However, few studies have explored the potential of multimodal MRI to predict motor capacity in ALS. This study aims to evaluate the predictive value of cervical spinal cord MRI parameters for motor capacity in ALS compared to clinical prognostic factors.
METHODS METHODS
Spinal multimodal MRI was performed shortly after diagnosis in 41 ALS patients and 12 healthy participants as part of a prospective multicenter cohort study, the PULSE study (NCT00002013-A00969-36). Motor capacity was assessed using ALSFRS-R scores. Multiple stepwise linear regression models were constructed to predict motor capacity at 3 and 6 months from diagnosis, based on clinical variables, structural MRI measurements, including spinal cord cross-sectional area (CSA), anterior-posterior, and left-to-right cross-section diameters at vertebral levels from C1 to T4, and diffusion parameters in the lateral corticospinal tracts (LCSTs) and dorsal columns.
RESULTS RESULTS
Structural MRI measurements were significantly correlated with the ALSFRS-R score and its sub-scores. And as early as 3 months from diagnosis, structural MRI measurements fit the best multiple linear regression model to predict the total ALSFRS-R (R
CONCLUSIONS CONCLUSIONS
Spinal multimodal MRI could be promising as a tool to enhance prognostic accuracy and serve as a motor function proxy in ALS.

Identifiants

pubmed: 37103756
doi: 10.1007/s00415-023-11727-w
pii: 10.1007/s00415-023-11727-w
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3885-3895

Investigateurs

Veronique Danel-Brunaud (V)
Caroline Moreau (C)
Thierry Perez (T)
None Dumont
K Dujardin (K)
Arnaud Delval (A)
Patrick Gelé (P)
Marie Pleuvret (M)
Valerie Santraine (V)
Francine Niset (F)
Julien Dumont (J)
Victor Laugeais (V)
Mathilde Bon (M)
Thavarak Ouk (T)
Camille Potey (C)
Celine Leclercq (C)
Elise Gers (E)
Francois Salachas (F)
Gaelle Bruneteau (G)
Lucette Lacomblez (L)
Julie Socha (J)
Fanny Pineau (F)
Timothee Lenglet (T)
Patricia Doucelance Stéphanie Folhinha (PDS)
Amandine Bordet (A)
Hugo Royer (H)
Nadia Osman (N)
Sabah Ait Khelifa (SA)
Philippe Corcia (P)
Stephane Beltran (S)
Delphine Carmier (D)
Laurent Barantin (L)
Hélène Blasco (H)
Salah Eddine Bakkouche (SE)
Mohad Mouzouri (M)
Jean-Christophe Antoine (JC)
Jean-Philippe Camdessanché (JP)
Nathalie Dimier (N)
Anne-Laure Kaminsky (AL)
Isabelle Court-Fortune (I)
Claire Boutet (C)
Philippe Gonzalo (P)
Vincent Visneux (V)
Karine Ferraud (K)
Georgette Berlier (G)
Steeve Genestet (S)
Christophe Gut-Gobert (C)
Douraied Ben Salem (DB)
Pauline Nicolas (P)
Sabine Larvor (S)
Kevin Mouly (K)
Liana Le Roux (LL)
Kevin Postec (K)
Camille Bezeazux (C)
Sylvain Rosec (S)
Hélène Fortin-Prunier (H)
Gaelle Novert (G)
Elsa Menanteau (E)
Kevin Postec (K)
Magali Denizot (M)
Emilien Bernard (E)
Christophe Vial (C)
Emmanuel Broussole (E)
Juliette Svahn (J)
Pierre Le Cam (PL)
Yves Berthezene (Y)
Philippe Combet (P)
Sophie Jacqueline (S)
Camille Neuillet (C)
Adeline Mansuy (A)
William Camu (W)
None Juntas-Morates
None Pageot
None Esselin
None Champfleur
None Roy-Bellina
Sylvain Lehmann (S)
Sebastien Alphandry (S)
Laura Labar (L)
Leandra Baudesson (L)
Sharam Attarian (S)
Aude-Marie Grapperon (AM)
Jean Pouget (J)
Annie Verschueren (A)
Jaochim Bas (J)
Armelle Finet-Monnier (A)
Carole Belingher (C)
Saran Diallo (S)
Nacime Heddadji (N)
Sebastien Alphandery (S)
Leandra Baudesson (L)
Pascale Reginensi (P)
Claude Desnuelle (C)
Marie-Hélene Soriani (MH)
S Chanalet (S)
Lydiane Mondot (L)
None Puma
Isabelle Pruvost (I)
Carole Barré (C)
Pascal Cintas (P)
Marie-Christine Arne Bes (MA)
Blandine Acket (B)
Jérémie Pariente (J)
Isabelle Guilbaud (I)
Fabrice Bonneville (F)
E Causse (E)
Thierry Lagarde (T)
Jeremy Geffroy (J)
Magali Centelles (M)
Véronique Hermet-Douard (V)
Sophie Pittion-Vouyovitch (S)
Maud Michon (M)
Mylène Meyer (M)
Sandra Lomazzi (S)
Gabriella Hossu (G)
Anne Chatelain (A)
Philippe Couratier (P)
Geraldine Lautrette (G)
Francois Vincent (F)
Larie-Therese Antonini (LT)
Florent Favard (F)
M L Arie-Paule Boncoeur-Martel (MLA)
Marianne Chouly (M)
Jean-Claude Desport (JC)
Pierre Jesus (P)
Phillipe Fayemendy (P)
Clémence Labetoulle (C)
Julie Catteau (J)
Olivier Villeneuve (O)
Selam Machat (S)
Nathalie Guy (N)
Pierre Clavelou (P)
Anick Greil (A)
M Duclos (M)
Betty Jean (B)
Carine Chassain (C)
Camille Tsoutsos (C)
Claudine Speziale (C)
Aurélie Cladiere (A)
C Bouteloup (C)
N Farigon (N)
Sophia Sickout Argondo (SS)
Emilie Dumont (E)
Sandrine Rouvet (S)
Fausto Viader (F)
Mathilde Lefilliatre (M)
Philippe Mouton (P)
A Mondou (A)
Stephane Allouche (S)
Rachida Bari-Makouri (R)
Ivan Kolev (I)
Morgane Pihan (M)
Helene Le Ho (HL)
Bertrand Catroux (B)
Maela Castel (M)
Marine Rigal (M)
Catherine Bellot (C)
Maelle Vomscheid (M)
Marie-Cécile Hervé (MC)
Marie-Pierre Duban (MP)
Anne Vieillart (A)
Julien Cassereau (J)
Philippe Codron (P)
Vivien Pautot (V)
Nicole Meslier (N)
Wojciech Trzepizur (W)
J Y Tanguy (JY)
Philippe Allain (P)
Cecile Thiery (C)
Pascal Reynier (P)
Tiphaine Barbe (T)
None Vialle-Soubranne
Nathalie Vienne (N)
Audrey Olivier (A)
Jeanne Miller (J)
Marie Bost (M)
None Fournier
David Gay (D)
Robin Bonicel (R)
Fouzia El Mountassir (F)
Clara Fischer (C)
Jean-François Mangin (JF)
Marie Chupin (M)
Yann Cointepas (Y)
Bertrand Accart (B)
Patrick Gelé (P)
Florine Fievet (F)
Matthieu Chabel (M)
Virginie Derenaucourt (V)
Loïc Facon (L)
Yanick Tchantchou Njosse (YT)
Michael Hisbergues (M)
None Deplanque
Christine Tabuenca (C)
Marie-France Cazalère (MF)
Philippe Couratier (P)
William Camu (W)
Philippe Corcia (P)
Claude Desnuelle (C)
Maxime Caillier (M)
Véronique Danel (V)
Caroline Morerau (C)
Victor Laugeais (V)
Amelie Lecocq (A)
Nathalie Potin (N)
Marie Frisch (M)
Marie Léon (M)
David Devos (D)
François Salachas (F)
Pierre-Francois Pradat (PF)
Lucette Lacomblez (L)
Jean-Philippe Camdessanché (JP)
Sharam Attarian (S)
Timothée Langlet (T)
Hélène Blasco (H)
Luc Dupuis (L)
Mathilde Bon (M)
Emilien Bernard (E)
Julien Cassereau (J)
Marie-Hélène Soriani (MH)
Cedric Raoul (C)
Sylvain Lehman (S)
Sabine Turgeman (S)
Valérie Goutines (V)

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Références

Robberecht W, Philips T (2013) The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 14:248–264. https://doi.org/10.1038/nrn3430
doi: 10.1038/nrn3430 pubmed: 23463272
Rowland LP, Shneider NA (2001) Amyotrophic lateral sclerosis. N Engl J Med 344:1688–1700. https://doi.org/10.1056/nejm200105313442207
doi: 10.1056/nejm200105313442207 pubmed: 11386269
Turner MR, Bowser R, Bruijn L, Dupuis L, Ludolph A, McGrath M, Manfredi G, Maragakis N, Miller RG, Pullman SL, Rutkove SB, Shaw PJ, Shefner J, Fischbeck KH (2013) Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14:19–32. https://doi.org/10.3109/21678421.2013.778554
doi: 10.3109/21678421.2013.778554 pubmed: 23678877 pmcid: 4284067
Turner MR, Benatar M (2015) Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis. Muscle Nerve 51:14–18. https://doi.org/10.1002/mus.24470
doi: 10.1002/mus.24470 pubmed: 25288265
Ravits J, Paul P, Jorg C (2007) Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 68:1571–1575. https://doi.org/10.1212/01.wnl.0000260965.20021.47
doi: 10.1212/01.wnl.0000260965.20021.47 pubmed: 17485643
Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, Rowland LP (2006) The natural history of primary lateral sclerosis. Neurology 66:647–653. https://doi.org/10.1212/01.wnl.0000200962.94777.71
doi: 10.1212/01.wnl.0000200962.94777.71 pubmed: 16534101
Kraemer M, Buerger M, Berlit P (2010) Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 112:103–105. https://doi.org/10.1016/j.clineuro.2009.10.014
doi: 10.1016/j.clineuro.2009.10.014 pubmed: 19931253
Witzel S, Frauhammer F, Steinacker P, Devos D, Pradat PF, Meininger V, Halbgebauer S, Oeckl P, Schuster J, Anders S, Dorst J, Otto M, Ludolph AC (2021) Neurofilament light and heterogeneity of disease progression in amyotrophic lateral sclerosis: development and validation of a prediction model to improve interventional trials. Transl Neurodegener 10:31. https://doi.org/10.1186/s40035-021-00257-y
doi: 10.1186/s40035-021-00257-y pubmed: 34433481 pmcid: 8390195
Cai Z, Liu Q, Liu M, Yang X, Shen D, Sun X, He D, Zhang K, Shang L, Zhang X, Cui L (2022) Survival analysis of clinical and genetic factors in an amyotrophic lateral sclerosis cohort from China. Neurol Res 44:651–658. https://doi.org/10.1080/01616412.2022.2029292
doi: 10.1080/01616412.2022.2029292 pubmed: 35193472
Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, Martin S, McDermott CJ, Thompson AG, Pinto S, Kobeleva X, Rosenbohm A, Stubendorff B, Sommer H, Middelkoop BM, Dekker AM, van Vugt J, van Rheenen W, Vajda A, Heverin M, Kazoka M, Hollinger H, Gromicho M, Körner S, Ringer TM, Rödiger A, Gunkel A, Shaw CE, Bredenoord AL, van Es MA, Corcia P, Couratier P, Weber M, Grosskreutz J, Ludolph AC, Petri S, de Carvalho M, Van Damme P, Talbot K, Turner MR, Shaw PJ, Al-Chalabi A, Chiò A, Hardiman O, Moons KGM, Veldink JH, van den Berg LH (2018) Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 17:423–433. https://doi.org/10.1016/s1474-4422(18)30089-9
doi: 10.1016/s1474-4422(18)30089-9 pubmed: 29598923
Trojsi F, Siciliano M, Femiano C, Santangelo G, Lunetta C, Calvo A, Moglia C, Marinou K, Ticozzi N, Ferro C, Scialò C, Sorarù G, Conte A, Falzone YM, Tortelli R, Russo M, Sansone VA, Chiò A, Mora G, Silani V, Volanti P, Caponnetto C, Querin G, Sabatelli M, Riva N, Logroscino G, Messina S, Fasano A, Monsurrò MR, Tedeschi G, Mandrioli J (2019) Comparative analysis of C9orf72 and sporadic disease in a large multicenter ALS population: the effect of male sex on survival of C9orf72 positive patients. Front Neurosci. https://doi.org/10.3389/fnins.2019.00485
doi: 10.3389/fnins.2019.00485 pubmed: 31849599 pmcid: 6901677
Ahmed RM, Devenney EM, Strikwerda-Brown C, Hodges JR, Piguet O, Kiernan MC (2020) Phenotypic variability in ALS-FTD and effect on survival. Neurology 94:e2005–e2013. https://doi.org/10.1212/wnl.0000000000009398
doi: 10.1212/wnl.0000000000009398 pubmed: 32277059
Zhou YN, Chen YH, Dong SQ, Yang WB, Qian T, Liu XN, Cheng Q, Wang JC, Chen XJ (2021) Role of blood neurofilaments in the prognosis of amyotrophic lateral sclerosis: a meta-analysis. Front Neurol. https://doi.org/10.3389/fneur.2021.712245
doi: 10.3389/fneur.2021.712245 pubmed: 35197917 pmcid: 8733999
El Mendili MM, Cohen-Adad J, Pelegrini-Issac M, Rossignol S, Morizot-Koutlidis R, Marchand-Pauvert V, Iglesias C, Sangari S, Katz R, Lehericy S, Benali H, Pradat PF (2014) Multi-parametric spinal cord MRI as potential progression marker in amyotrophic lateral sclerosis. PLoS ONE 9:e95516. https://doi.org/10.1371/journal.pone.0095516
doi: 10.1371/journal.pone.0095516 pubmed: 24755826 pmcid: 3995720
European Medicines Agency. Guideline on clinical investigation of medicinal products for the treatment of amyotrophic lateral sclerosis 2016 [Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-investigation-medicinal-products-treatment-amyotrophic-lateral-sclerosis_en.pdf . Accessed 06 Oct 2022.
U.S. Food and Drug Administration. Guidance for industry: amyotrophic lateral sclerosis: developing drugs for treatment 2019 [Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/amyotrophic-lateral-sclerosis-developing-drugs-treatment-guidance-industry .
Steering committee members of The ALS CNTF Treatment Study Phase I-II Study Group (1996) The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol 53:141–147. https://doi.org/10.1001/archneur.1996.00550020045014
doi: 10.1001/archneur.1996.00550020045014
van Eijk R, Kliest T, van den Berg L (2020) Current trends in the clinical trial landscape for amyotrophic lateral sclerosis. Curr Opin Neurol 33:655–661. https://doi.org/10.1097/WCO.0000000000000861
doi: 10.1097/WCO.0000000000000861 pubmed: 32796282
Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377:942–955. https://doi.org/10.1016/s0140-6736(10)61156-7
doi: 10.1016/s0140-6736(10)61156-7 pubmed: 21296405
El Mendili MM, Querin G, Bede P, Pradat P-F (2019) Spinal cord imaging in amyotrophic lateral sclerosis: historical concepts—novel techniques. Front Neurol 10:350. https://doi.org/10.3389/fneur.2019.00350
doi: 10.3389/fneur.2019.00350 pubmed: 31031688 pmcid: 6474186
Cohen-Adad J, El Mendili MM, Morizot-Koutlidis R, Lehéricy S, Meininger V, Blancho S, Rossignol S, Benali H, Pradat PF (2013) Involvement of spinal sensory pathway in ALS and specificity of cord atrophy to lower motor neuron degeneration. Amyotroph Lateral Scler Frontotemporal Degener 14:30–38. https://doi.org/10.3109/17482968.2012.701308
doi: 10.3109/17482968.2012.701308 pubmed: 22881412
Branco LM, De Albuquerque M, De Andrade HM, Bergo FP, Nucci A, França MC Jr (2014) Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 15:93–97. https://doi.org/10.3109/21678421.2013.852589
doi: 10.3109/21678421.2013.852589 pubmed: 24219347
Nair G, Carew JD, Usher S, Lu D, Hu XP, Benatar M (2010) Diffusion tensor imaging reveals regional differences in the cervical spinal cord in amyotrophic lateral sclerosis. Neuroimage 53:576–583. https://doi.org/10.1016/j.neuroimage.2010.06.060
doi: 10.1016/j.neuroimage.2010.06.060 pubmed: 20600964
Querin G, El Mendili MM, Lenglet T, Delphine S, Marchand-Pauvert V, Benali H, Pradat PF (2017) Spinal cord multi-parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosis. Eur J Neurol 24:1040–1046. https://doi.org/10.1111/ene.13329
doi: 10.1111/ene.13329 pubmed: 28586096
Grolez G, Kyheng M, Lopes R, Moreau C, Timmerman K, Auger F, Kuchcinski G, Duhamel A, Jissendi-Tchofo P, Besson P, Laloux C, Petrault M, Devedjian JC, Pérez T, Pradat PF, Defebvre L, Bordet R, Danel-Brunaud V, Devos D (2018) MRI of the cervical spinal cord predicts respiratory dysfunction in ALS. Sci Rep 8:1828. https://doi.org/10.1038/s41598-018-19938-2
doi: 10.1038/s41598-018-19938-2 pubmed: 29379040 pmcid: 5789036
Querin G, El Mendili MM, Bede P, Delphine S, Lenglet T, Marchand-Pauvert V, Pradat PF (2018) Multimodal spinal cord MRI offers accurate diagnostic classification in ALS. J Neurol Neurosurg Psychiatry 89:1220–1221. https://doi.org/10.1136/jnnp-2017-317214
doi: 10.1136/jnnp-2017-317214 pubmed: 29353238
Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299. https://doi.org/10.1080/146608200300079536
doi: 10.1080/146608200300079536 pubmed: 11464847
Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13–21. https://doi.org/10.1016/s0022-510x(99)00210-5
doi: 10.1016/s0022-510x(99)00210-5 pubmed: 10540002
Gros C, De Leener B, Dupont SM, Martin AR, Fehlings MG, Bakshi R, Tummala S, Auclair V, McLaren DG, Callot V, Cohen-Adad J, Sdika M (2018) Automatic spinal cord localization, robust to MRI contrasts using global curve optimization. Med Image Anal 44:215–227. https://doi.org/10.1016/j.media.2017.12.001
doi: 10.1016/j.media.2017.12.001 pubmed: 29288983
Fonov VS, Le Troter A, Taso M, De Leener B, Lévêque G, Benhamou M, Sdika M, Benali H, Pradat PF, Collins DL, Callot V, Cohen-Adad J (2014) Framework for integrated MRI average of the spinal cord white and gray matter: the MNI-Poly-AMU template. Neuroimage 102:2817–2827. https://doi.org/10.1016/j.neuroimage.2014.08.057
doi: 10.1016/j.neuroimage.2014.08.057
Lévy S, Benhamou M, Naaman C, Rainville P, Callot V, Cohen-Adad J (2015) White matter atlas of the human spinal cord with estimation of partial volume effect. Neuroimage 119:262–271. https://doi.org/10.1016/j.neuroimage.2015.06.040
doi: 10.1016/j.neuroimage.2015.06.040 pubmed: 26099457
Jiao Y, Lin F, Wu J, Li H, Wang L, Jin Z, Wang S, Cao Y (2018) A supplementary grading scale combining lesion-to-eloquence distance for predicting surgical outcomes of patients with brain arteriovenous malformations. J Neurosurg 128:530–540. https://doi.org/10.3171/2016.10.Jns161415
doi: 10.3171/2016.10.Jns161415 pubmed: 28362235
Sabatelli M, Madia F, Conte A, Luigetti M, Zollino M, Mancuso I, Lo Monaco M, Lippi G, Tonali P (2008) Natural history of young-adult amyotrophic lateral sclerosis. Neurology 71:876–881. https://doi.org/10.1212/01.wnl.0000312378.94737.45
doi: 10.1212/01.wnl.0000312378.94737.45 pubmed: 18596241
Chen L, Zhang B, Chen R, Tang L, Liu R, Yang Y, Yang Y, Liu X, Ye S, Zhan S, Fan D (2015) Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China. J Neurol Neurosurg Psychiatry 86:1075–1081. https://doi.org/10.1136/jnnp-2015-310471
doi: 10.1136/jnnp-2015-310471 pubmed: 26124198
Paquin M, El Mendili MM, Gros C, Dupont SM, Cohen-Adad J, Pradat PF (2018) Spinal cord gray matter atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 39:184–192. https://doi.org/10.3174/ajnr.A5427
doi: 10.3174/ajnr.A5427 pubmed: 29122760 pmcid: 7410702
Barry RL, Torrado-Carvajal A, Kirsch JE, Arabasz GE, Albrecht DS, Alshelh Z, Pijanowski O, Lewis AJ, Keegan M, Reynolds B, Knight PC, Morrissey EJ, Loggia ML, Atassi N, Hooker JM, Babu S (2022) Selective atrophy of the cervical enlargement in whole spinal cord MRI of amyotrophic lateral sclerosis. NeuroImage Clin 36:103199. https://doi.org/10.1016/j.nicl.2022.103199
doi: 10.1016/j.nicl.2022.103199 pubmed: 36137496 pmcid: 9668597
Bede P, Hardiman O (2014) Lessons of ALS imaging: Pitfalls and future directions—a critical review. NeuroImage Clin 4:436–443. https://doi.org/10.1016/j.nicl.2014.02.011
doi: 10.1016/j.nicl.2014.02.011 pubmed: 24624329 pmcid: 3950559
Cao B, Wei Q, Ou R, Zhang L, Hou Y, Chen Y, Shang H (2019) Neurophysiological index is associated with the survival of patients with amyotrophic lateral sclerosis. Clin Neurophysiol 130:1730–1733. https://doi.org/10.1016/j.clinph.2019.05.012
doi: 10.1016/j.clinph.2019.05.012 pubmed: 31164255

Auteurs

M Khamaysa (M)

Sorbonne Université, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, Paris, France.

M Lefort (M)

Sorbonne Université, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, Paris, France.

M Pélégrini-Issac (M)

Sorbonne Université, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, Paris, France.

A Lackmy-Vallée (A)

Sorbonne Université, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, Paris, France.

A Preuilh (A)

Sorbonne Université, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, Paris, France.

D Devos (D)

Département de Neurology, Centre Référent SLA, CHU de Lille, Centre LICEND COEN, Lille, France.
Départment de Pharmacologie Médicale, Université de Lille, INSERM UMRS_1172 LilNCog, CHU de Lille, Centre LICEND COEN, Lille, France.

A-S Rolland (AS)

Départment de Pharmacologie Médicale, Université de Lille, INSERM UMRS_1172 LilNCog, CHU de Lille, Centre LICEND COEN, Lille, France.

C Desnuelle (C)

Faculté Médecine de Nice, Département de Neurologie, Université Cote d'Azur, Nice, France.

M Chupin (M)

CATI Multicenter Neuroimaging Platform, Paris, France.

V Marchand-Pauvert (V)

Sorbonne Université, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, Paris, France.

G Querin (G)

APHP, Service de Neuromyologie, Hôpital Pitié-Salpêtrière, Centre Référent Maladies Neuromusculaires Rares, Paris, France.
Institut de Myologie, I-Motion Clinical Trials Platform, Hôpital Pitié-Salpêtrière, Paris, France.

Pierre-François Pradat (PF)

Sorbonne Université, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, Paris, France. pierre-francois.pradat@aphp.fr.
APHP, Département de Neurologie, Hôpital Pitié-Salpêtrière, Centre Référent SLA, Paris, France. pierre-francois.pradat@aphp.fr.
Northern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute Ulster University, C-TRIC, Altnagelvin Hospital, Derry/Londonderry, UK. pierre-francois.pradat@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH